Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2005 Filed Apr 18, 2005 18:34 UTC |
DALEY WILLIAM MDirector
|
Purchasecommon shares without par value | 1,000 | $49.81 | $49,810.00 |
DisclosureSEC source: 0001104659-05-016841 · a4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| April 15, 2005 Filed Apr 19, 2005 15:31 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 28,771 | $0.00 Strike: $48.29 | $0.00 |
DisclosureSEC source: 0001104659-05-016998 · a4.xml · derivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,771 Underlying: common shares · 28,771 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 15, 2005 Filed Apr 19, 2005 15:31 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 35,468 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-016998 · a4.xml · derivative · entry 4 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,468 Underlying: common shares · 35,468 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 15, 2005 Filed Apr 19, 2005 15:31 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Tax withholdingCommon shares without par value | 28,771 | $48.29 | $1,389,351.59 |
DisclosureSEC source: 0001104659-05-016998 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,606 Read SEC document |
| April 15, 2005 Filed Apr 19, 2005 15:31 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionCommon shares without par value | 35,468 | $33.23 | $1,178,651.30 |
DisclosureSEC source: 0001104659-05-016998 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2005 Filed Apr 4, 2005 20:23 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 268 | $46.62 Strike: $0.00 | $12,494.16 |
DisclosureSEC source: 0001104659-05-014996 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,322 Underlying: common shares · 268 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2005 Filed Apr 4, 2005 20:27 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 493 | $46.62 Strike: $0.00 | $22,983.66 |
DisclosureSEC source: 0001104659-05-015001 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,734 Underlying: common shares · 493 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · kind: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2005 Filed Apr 4, 2005 20:30 UTC |
DALEY WILLIAM MDirector
|
GrantStock equivalent units · Derivative | 429 | $46.62 Strike: $0.00 | $19,999.98 |
DisclosureSEC source: 0001104659-05-015002 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716 Underlying: common shares · 429 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · kind: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2005 Filed Apr 4, 2005 22:16 UTC |
RAND A BARRYDirector
|
GrantStock equivalent units · Derivative | 77 | $46.62 Strike: $0.00 | $3,589.74 |
DisclosureSEC source: 0001104659-05-015058 · a4.xml · derivative · entry 1 RAND A BARRY · CIK 0001012979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723 Underlying: common shares · 77 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 24, 2005 Filed Mar 28, 2005 20:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 224,097 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0001104659-05-013074 · a4.xml · derivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,097 Underlying: common shares · 224,097 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from 16(b) under Rule 16b-3. Read SEC document |
| March 24, 2005 Filed Mar 28, 2005 20:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 267,663 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-05-013074 · a4.xml · derivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,553 Underlying: common shares · 267,663 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from 16(b) under Rule 16b-3. Read SEC document |
| March 24, 2005 Filed Mar 28, 2005 20:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 51,695 | $0.00 Strike: $39.62 | $0.00 |
DisclosureSEC source: 0001104659-05-013074 · a4.xml · derivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 51,695 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from 16(b) under Rule 16b-3. Read SEC document |
| March 24, 2005 Filed Mar 28, 2005 20:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 272,299 | $44.60 | $12,144,535.40 |
DisclosureSEC source: 0001104659-05-013074 · a4.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647,496 Read SEC document |
| March 24, 2005 Filed Mar 28, 2005 20:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 267,663 | $32.61 | $8,728,784.86 |
DisclosureSEC source: 0001104659-05-013074 · a4.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2005 Filed Mar 28, 2005 20:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 51,695 | $39.62 | $2,048,259.29 |
DisclosureSEC source: 0001104659-05-013074 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2005 Filed Apr 14, 2005 18:32 UTC |
LINDER GREG WVice President
|
GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-016449 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,341 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 20:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 29,290 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010375 · a4.xml · derivative · entry 7 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,290 Underlying: common shares · 29,290 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 20:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 35,468 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010375 · a4.xml · derivative · entry 6 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,468 Underlying: common shares · 35,468 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 20:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 15,894 | $0.00 Strike: $41.97 | $0.00 |
DisclosureSEC source: 0001104659-05-010375 · a4.xml · derivative · entry 5 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 15,894 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 20:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 44,219 | $46.65 | $2,062,816.35 |
DisclosureSEC source: 0001104659-05-010375 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,263 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 20:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 35,468 | $33.23 | $1,178,651.30 |
DisclosureSEC source: 0001104659-05-010375 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 20:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 15,894 | $41.97 | $667,095.02 |
DisclosureSEC source: 0001104659-05-010375 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
NEMMERS JOSEPH MSenior Vice President
|
GrantOption (right to buy) · Derivative | 4,623 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,623 Underlying: common shares · 4,623 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
NEMMERS JOSEPH MSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,597 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,964 Underlying: common shares · 5,597 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
NEMMERS JOSEPH MSenior Vice President
|
Tax withholdingCommon shares without par value | 4,623 | $46.65 | $215,662.95 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,504 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
NEMMERS JOSEPH MSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,597 | $33.23 | $185,996.15 |
DisclosureSEC source: 0001104659-05-010425 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 15,473 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 Underlying: common shares · 15,473 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 18,736 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,735 Underlying: common shares · 18,736 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,661 | $0.00 Strike: $18.39 | $0.00 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 6,661 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 18,099 | $46.65 | $844,318.35 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,441 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 18,736 | $33.23 | $622,623.51 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 6,661 | $18.39 | $122,508.45 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 37,256 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,256 Underlying: common shares · 37,256 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 2,142 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,142 Underlying: common shares · 2,142 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 2,142 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,142 Underlying: common shares · 2,142 shares Expires 2007-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 45,113 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,711 Underlying: common shares · 45,113 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 10,653 | $0.00 Strike: $39.98 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 10,653 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 3,643 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,643 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 51,270 | $46.65 | $2,391,745.50 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,604 Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 45,113 | $33.23 | $1,499,168.15 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 10,653 | $39.98 | $425,897.35 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 3,065 | $32.61 | $99,953.02 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 3,643 | $27.43 | $99,937.69 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2005 Filed Mar 2, 2005 18:58 UTC |
Schumacher Laura JSenior Vice President
|
GrantCommon shares without par value | 10,000 | $46.12 | $461,200.00 |
DisclosureSEC source: 0001104659-05-009093 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,871 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 440,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008008 · a4.xml · derivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,800 Underlying: common shares · 440,800 shares Expires 2015-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 146,934 on 2/18/06, 146,933 on 2/18/07 and 146,933 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 63,800 | $46.34 | $2,956,492.00 |
DisclosureSEC source: 0001104659-05-008008 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,437 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 313,200 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008010 · a4.xml · derivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,200 Underlying: common shares · 313,200 shares Expires 2015-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 104,400 on 2/18/06, 104,400 on 2/18/07 and 104,400 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantCommon shares without par value | 46,400 | $46.34 | $2,150,176.00 |
DisclosureSEC source: 0001104659-05-008010 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,400 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantOption (right to buy) · Derivative | 313,200 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008009 · a4.xml · derivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,200 Underlying: common shares · 313,200 shares Expires 2015-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 104,400 on 2/18/06, 104,400 on 2/18/07 and 104,400 on 2/18/08. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.